EORTC study 26041-22041: phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma (Q33387221)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | EORTC study 26041-22041: phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma |
scientific article |
Statements
1 reference
EORTC study 26041-22041: phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma (English)
1 reference
Roger Stupp
1 reference
Peter Hau
1 reference
Denis Lacombe
1 reference
Thierry Gorlia
1 reference
Alicia Tosoni
1 reference
Renè O Mirimanoff
1 reference
Johan M Kros
1 reference
Martin J van den Bent
1 reference
27 November 2009
1 reference
1 reference
Identifiers
1 reference